Open AccessSurvival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis
Author(s) -
Marion Haubitz
Publication year - 1998
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/13.7.1713
Subject(s) - medicine , vasculitis , anti neutrophil cytoplasmic antibody , dialysis , cyclophosphamide , end stage renal disease , hemodialysis , kidney disease , systemic vasculitis , disease , survival rate , stage (stratigraphy) , surgery , gastroenterology , chemotherapy , paleontology , biology
In patients with end-stage renal disease (ESRD) due to Wegener's granulomatosis, a decrease in vasculitis activity after the development of ESRD, as described in other autoimmune diseases, has been postulated. However, up to now no data in a larger group of patients with Wegener's granulomatosis on chronic dialysis have been available.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom